Proteomic analysis of apoptosis induction in human lung cancer cells by recombinant MVL
- 312 Downloads
Lung cancer is still difficult to treat by current chemotherapeutic procedures. We recently found that MVL, an anti-HIV lectin from blue-green algae Microcystis viridis, also has antitumor activity. The objective of this study was to investigate apoptosis-inducing activity of recombinant MVL (R-MVL) and proteomic changes in A549 cells, and to identify the molecular pathways responsible for the anti-cancer action of R-MVL. We found that R-MVL induces A549 cells apoptosis in a dose-dependent manner by using MTT assay, fluorescent microscope (FM) and flow cytometry (FCM), and the IC50 was calculated to be 24.12 μg/ml. Subsequently, 7 altered proteins in R-MVL-treated A549 cells were identified, including upregulated aldehyde dehydrogenase 1 and β-actin, and five downregulated proteins: heat shock protein 90, heat shock 60, plastin 3, tropomyosin 3, and β-tubulin. Further bioinformatics analysis predicted the potential pathways for R-MVL to induce apoptosis of A549 cells. In conclusion, this is the first report to investigate anti-cancer activity of R-MVL and its mechanism of action by proteomics analysis. Our observations provide potential therapeutic targets for lung cancer inhibitor intervention and implicated the development of novel anti-cancer therapeutic strategies.
KeywordsRecombinant MVL Lung cancer Apoptosis Proteomics Pathways Bioinformatics
Conflict of interest
The authors declare that they have no conflict of interest.
- Xiao T, Ying WT, Li L, Hu Z, Ma Y, Jiao LY, Ma JF, Cai Y, Lin DM, Guo SP, Han NJ, Di XB, Li M, Zhang DC, Su K, Yuan JS, Zheng HW, Gao MX, He J, Shi SS, Li WJ, Xu NZ, Zhang HS, Liu Y, Zhang KT, Gao YN, Qian XH, Cheng SJ (2005) An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 4(10):1480–1486PubMedCrossRefGoogle Scholar